AR035837A1 - Benzodiazepinas triciclicas como antagonistas del receptor de vasopresina y compuestos intermediarios - Google Patents
Benzodiazepinas triciclicas como antagonistas del receptor de vasopresina y compuestos intermediariosInfo
- Publication number
- AR035837A1 AR035837A1 ARP000100214A ARP000100214A AR035837A1 AR 035837 A1 AR035837 A1 AR 035837A1 AR P000100214 A ARP000100214 A AR P000100214A AR P000100214 A ARP000100214 A AR P000100214A AR 035837 A1 AR035837 A1 AR 035837A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- group
- heteroaryl
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se refiere a benzodiazepinas tricíclicas útiles como antagonistas del receptor de vasopresina para tratar condiciones que involucran incrementada resistencia vascular. También se describen composiciones farmacéuticas que comprenden a las benzodiazepinas tricíclicas de la presente útiles para el tratamiento de condiciones como ser hipertensión, insuficiencia cardíaca congestiva, insuficiencia cardíaca, vasoespasmo coronario, isquemia cardíaca, cirrosis del hígado, vasoespasmo renal, insuficiencia renal, edema cerebral e isquemia, ataque apoplético, trombosis o retención de agua. Benzodiazepinas tricíclicas, caracterizadas porque comprenden un compuesto de la fórmula (1) o (2), en donde: m es un entero de 1 a 2; con la condición de que si m es 1 o 2, entonces ''HET'' en el compuesto de la fórmula (2) es un sistema de anillos aromáticos monocíclicos de 5 o 6 miembros estable compuesto por átomos de carbono y un heteroátomo, en donde el heteroátomo se selecciona entre el grupo que consiste en N, O y S el cual puede estar adherido a cualquier heteroátomo o átomo de carbono mediante lo cual el sistema de anillo resultante es estable; A se selecciona entre el grupo que consiste en -C(O)-, SO2 y CH2; Y se selecciona entre el grupo que consiste en CH2 y CH como parte de una olefina; X se selecciona entre el grupo que consiste en CH2, CH como parte de una olefina, NR3, S y O; con la condición de que si Y es CH2, entonces X es (CH2)2; Z se selecciona entre el grupo que consiste en N y CH; R1 se selecciona entre el grupo que consiste en hidrógeno, alquilo, alcoxi, halógeno, aminoalquilo y nitro; Ar se selecciona entre naftilo, en donde naftilo es optativamente sustituido con entre 1 a 3 sustituyentes independientemente seleccionados entre alquilo C1-8, alcoxi C1-8, alquilo C1-8 tratado con flúor, alcoxi C1-8 tratado con flúor, halógeno, ciano, hidroxi, amino, nitro, alquilamino C1-4, dialquilamino C1-4, en donde los grupos alquilo pueden ser iguales o diferentes; o fenilo, en donde fenilo es optativamente sustituido con entre uno a tres sustituyentes seleccionados independientemente entre alquilo C1-8, alcoxi C1-8, alquilo C1-8 tratado con flúor, alcoxi C1-8 tratado con flúor, aralquilo C1-8 (en donde optativamente las porciones alquilo o arilo son independientemente sustituidas y la porción alquilo puede ser sustituida con por lo menos un flúor y/o la porción arilo puede ser independientemente sustituida con entre uno a dos sustituyentes seleccionados entre halógeno, alquilo C1-4, alquiltio C1-6 o hidroxilo), aralcoxi C1-8 en donde optativamente las porciones alcoxi o arilo son independientemente sustituidas y la porción alcoxi puede ser sustituida con por lo menos un flúor y/o la porción arilo puede ser independientemente sustituida con entre uno a dos sustituyentes seleccionados entre halógeno, alquilo C1-4, alquiltio C1-6 o hidroxilo), halógeno, ciano, hidroxi, amino, nitro, alquilamino C1-8, dialquilamino C1-4 (en donde los grupos alquilo pueden ser iguales o diferentes), alquilsulfonilo C1-8, alquiltio C1-8, alquilsulfinilo C1-8, heteroarilo, un segundo fenilo (en donde el segundo fenilo es optativamente sustituido con entre uno a dos sustituyentes independientemente seleccionados entre alquilo C1-4, alcoxi C1-4, alquilo C1-4 tratado con flúor, alcoxi C1-4 tratado con flúor, halógeno, ciano, hidroxi, amino, nitro, alquilamino C1-4, dialquilamino C1-4 [en donde los grupos alquilo pueden ser iguales o diferentes], alquilsulfonilo C1-4, alquiltio C1-4 o alquilsulfinilo C1-4; R2 se selecciona entre el grupo que consiste en hidrógeno, NR4COAr, NR4CO-heteroarilo, NR4Ar, CH=CH-Ar, CF=CH-Ar, CH=CF-Ar, CCl=CH-Ar, CH=CCl-Ar. CH=CH-heteroarilo, CF=CH-heteroarilo, CH=CF-heteroarilo, CCl=CH-heteroarilo, CH=CCl-heteroarilo, OCH2-Ar, OCH2-heteroarilo, SCH2-Ar y NR4CH2Ar; R3 se selecciona entre el grupo que consiste en hidrógeno, acilo, alquilo, alcoxicarbonilo, alquilsulfonilo y arilsulfonilo; R4 se selecciona entre el grupo que consiste en hidrógeno y alquilo C1-4; R5 se selecciona entre el grupo que consiste en hidrógeno, alquilo C1-4, alcoxi C1-4, cloro, flúor, hidroxi, dialquilamino (en donde los grupos alquilo pueden ser iguales o diferentes), trifluorometilo o trifluorometoxi; y sus sales farmacéuticamente aceptables.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11635899P | 1999-01-19 | 1999-01-19 | |
US46865099A | 1999-12-21 | 1999-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR035837A1 true AR035837A1 (es) | 2004-07-21 |
Family
ID=26814157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100214A AR035837A1 (es) | 1999-01-19 | 2000-01-18 | Benzodiazepinas triciclicas como antagonistas del receptor de vasopresina y compuestos intermediarios |
Country Status (27)
Country | Link |
---|---|
US (2) | US6713475B2 (es) |
EP (1) | EP1147115B3 (es) |
KR (1) | KR100771184B1 (es) |
CN (1) | CN1174986C (es) |
AR (1) | AR035837A1 (es) |
AT (1) | ATE249465T1 (es) |
AU (1) | AU772397B2 (es) |
BR (1) | BRPI9917086B8 (es) |
CA (1) | CA2360767C (es) |
CZ (1) | CZ302647B6 (es) |
DE (2) | DE69911259T4 (es) |
DK (1) | DK1147115T5 (es) |
ES (1) | ES2207333T7 (es) |
HK (1) | HK1038361B (es) |
HU (1) | HU229074B1 (es) |
IL (2) | IL144270A0 (es) |
ME (1) | ME00129B (es) |
MY (1) | MY128065A (es) |
NO (1) | NO327896B1 (es) |
NZ (1) | NZ512960A (es) |
PL (1) | PL205704B1 (es) |
PT (1) | PT1147115E (es) |
RS (1) | RS50820B (es) |
TR (1) | TR200102069T2 (es) |
TW (1) | TWI289564B (es) |
UA (1) | UA70984C2 (es) |
WO (1) | WO2000043398A2 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2207333T7 (es) * | 1999-01-19 | 2009-06-18 | Orto-Mcneil Pharmaceutical, Inc. | Benzodiazepinas triciclicas utilizadas como antagonistas del receptor de la vasopresina. |
IL145684A (en) * | 2000-10-04 | 2007-06-17 | Warner Lambert Co | Medications for the treatment of pulmonary hypertension |
DE60222879T2 (de) | 2001-04-12 | 2008-07-24 | Wyeth | Cyclohexylphenyl vasopressin agonisten |
DK1381370T3 (da) | 2001-04-12 | 2007-05-21 | Wyeth Corp | N-Biphenylcarbonyl- og N-phenylpyridylcarbonyl-substituerede bi- og tricykliske azepiner og diazepiner som vasopressin-agonister |
DE60220305T2 (de) * | 2001-10-29 | 2008-01-17 | Ortho-Mcneil Pharmaceutical, Inc. | Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten |
EP1364968A1 (en) * | 2002-05-23 | 2003-11-26 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (AVPR1) |
GB0303852D0 (en) * | 2003-02-19 | 2003-03-26 | Pfizer Ltd | Triazole compounds useful in therapy |
US7119088B2 (en) | 2003-02-19 | 2006-10-10 | Pfizer Inc. | Triazole compounds useful in therapy |
PT1597260E (pt) * | 2003-02-19 | 2007-01-31 | Pfizer | Composto de triazole úteis em terapia |
CA2585449A1 (en) | 2004-10-28 | 2006-05-11 | Janssen Pharmaceutica N.V. | Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
US20070213813A1 (en) * | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
WO2008007661A1 (fr) * | 2006-07-11 | 2008-01-17 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique tricycique et son utilisation |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
BR112012021347A2 (pt) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente |
PL2356123T3 (pl) * | 2008-11-13 | 2013-03-29 | Hoffmann La Roche | Spiro-5,6-dihudro-4h-2,3,5,10b- tetraazabenzo[e]azuleny |
DK2358714T3 (da) * | 2008-11-18 | 2012-08-20 | Hoffmann La Roche | Alkylcyclohexylethere af dihydrotetraazabenzoazulener |
BRPI0922303B1 (pt) | 2008-11-28 | 2019-11-12 | Hoffmann La Roche | arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos, seu processo de preparação, composição farmacêutica que os compreende e uso |
DE102009033392A1 (de) * | 2009-07-16 | 2011-01-20 | Merck Patent Gmbh | Heterocyclische Verbindungen als Autotaxin-Inhibitoren II |
CN102510859A (zh) | 2009-09-24 | 2012-06-20 | 希里-莫韦蒂斯有限公司 | 用作为加压素v2受体拮抗剂的[1,4]-苯二氮 |
US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
WO2011147849A1 (en) | 2010-05-25 | 2011-12-01 | Jenavalve Technology Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US8828989B2 (en) | 2011-09-26 | 2014-09-09 | Hoffmann-La Roche Inc. | Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists |
EP4098226A1 (en) | 2013-08-30 | 2022-12-07 | JenaValve Technology, Inc. | Endoprosthesis comprising a radially collapsible frame and a prosthetic valve |
WO2016089833A1 (en) * | 2014-12-05 | 2016-06-09 | Merck Sharp & Dohme Corp. | Novel tricyclic compounds as inhibitors of mutant idh enzymes |
WO2016089797A1 (en) * | 2014-12-05 | 2016-06-09 | Merck Sharp & Dohme Corp. | Novel tricyclic compounds as inhibitors of mutant idh enzymes |
US10508108B2 (en) | 2014-12-05 | 2019-12-17 | Merck Sharp & Dohme Corp. | Tricyclic compounds as inhibitors of mutant IDH enzymes |
CN107530168B (zh) | 2015-05-01 | 2020-06-09 | 耶拿阀门科技股份有限公司 | 在心脏瓣膜替换中具有降低的起搏器比例的装置和方法 |
EP4183371A1 (en) | 2016-05-13 | 2023-05-24 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
CN110392557A (zh) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | 心脏瓣膜模拟 |
EP3875078A1 (en) * | 2020-03-06 | 2021-09-08 | Dompe' Farmaceutici S.P.A. | Compounds for the treatment of covid-19 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3732212A (en) | 1970-04-20 | 1973-05-08 | Sterling Drug Inc | 1,2,3,10,11,11a-hexahydro-5h-pyrrolo(2,1-c)(1,4)benzodiazepine-5,11-diones |
US3860600A (en) | 1972-07-10 | 1975-01-14 | Sterling Drug Inc | Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines |
US3763183A (en) * | 1972-07-10 | 1973-10-02 | Sterling Drug Inc | 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines |
US5516774A (en) * | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
US5521173A (en) * | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
WO1998043976A1 (fr) * | 1997-03-31 | 1998-10-08 | Wakamoto Pharmaceutical Co., Ltd. | Derives de biphenyle et compositions medicinales |
ES2229525T3 (es) * | 1997-07-30 | 2005-04-16 | Wyeth | Agonistas triciclicos de la vasopresina. |
ES2207333T7 (es) * | 1999-01-19 | 2009-06-18 | Orto-Mcneil Pharmaceutical, Inc. | Benzodiazepinas triciclicas utilizadas como antagonistas del receptor de la vasopresina. |
-
1999
- 1999-12-21 ES ES99966495T patent/ES2207333T7/es active Active
- 1999-12-21 HU HU0105034A patent/HU229074B1/hu not_active IP Right Cessation
- 1999-12-21 WO PCT/US1999/030423 patent/WO2000043398A2/en active IP Right Grant
- 1999-12-21 BR BRPI9917086A patent/BRPI9917086B8/pt not_active IP Right Cessation
- 1999-12-21 PT PT99966495T patent/PT1147115E/pt unknown
- 1999-12-21 TR TR2001/02069T patent/TR200102069T2/xx unknown
- 1999-12-21 AT AT99966495T patent/ATE249465T1/de active
- 1999-12-21 DE DE69911259T patent/DE69911259T4/de not_active Expired - Lifetime
- 1999-12-21 NZ NZ512960A patent/NZ512960A/en not_active IP Right Cessation
- 1999-12-21 KR KR1020017009039A patent/KR100771184B1/ko not_active IP Right Cessation
- 1999-12-21 ME MEP-2008-178A patent/ME00129B/me unknown
- 1999-12-21 UA UA2001075136A patent/UA70984C2/uk unknown
- 1999-12-21 DE DE69911259A patent/DE69911259D1/de not_active Expired - Lifetime
- 1999-12-21 IL IL14427099A patent/IL144270A0/xx unknown
- 1999-12-21 PL PL349778A patent/PL205704B1/pl unknown
- 1999-12-21 CA CA002360767A patent/CA2360767C/en not_active Expired - Fee Related
- 1999-12-21 CZ CZ20012598A patent/CZ302647B6/cs not_active IP Right Cessation
- 1999-12-21 CN CNB998164887A patent/CN1174986C/zh not_active Expired - Fee Related
- 1999-12-21 AU AU22014/00A patent/AU772397B2/en not_active Ceased
- 1999-12-21 EP EP99966495A patent/EP1147115B3/en not_active Expired - Lifetime
- 1999-12-21 DK DK99966495T patent/DK1147115T5/da active
-
2000
- 2000-01-18 AR ARP000100214A patent/AR035837A1/es active IP Right Grant
- 2000-01-19 MY MYPI20000169A patent/MY128065A/en unknown
- 2000-02-24 TW TW089100772A patent/TWI289564B/zh not_active IP Right Cessation
- 2000-12-21 RS YUP-519/01A patent/RS50820B/sr unknown
-
2001
- 2001-07-11 IL IL144270A patent/IL144270A/en not_active IP Right Cessation
- 2001-07-16 NO NO20013515A patent/NO327896B1/no not_active IP Right Cessation
- 2001-07-24 US US09/911,605 patent/US6713475B2/en not_active Expired - Lifetime
-
2002
- 2002-01-04 HK HK02100064.9A patent/HK1038361B/zh not_active IP Right Cessation
-
2004
- 2004-02-10 US US10/775,675 patent/US7317005B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR035837A1 (es) | Benzodiazepinas triciclicas como antagonistas del receptor de vasopresina y compuestos intermediarios | |
AR011174A1 (es) | Compuestos de pirazina, composiciones farmaceuticas que los contienen, su uso en la peparacion de medicamentos y proceso para prepararlos | |
ES2583642T3 (es) | Composiciones y métodos para la inhibición de la ruta de JAK | |
AR032353A1 (es) | Compuestos derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal y su uso en la fabricacion de medicamentos y composicion farmaceutica que los contiene | |
AR039189A1 (es) | Compuesto de pirrolopiridazina, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion | |
UY25682A1 (es) | Procedimiento para preparar derivados de quinolin-2-ona alquinilsustituidos útiles como agentes anticancerosos entre otras acciones terapéuticas | |
AR042532A1 (es) | Compuestos de 5,8-dihidro-6h-pirido[2,3-d]pirimidin-7-ona | |
CA2119572A1 (en) | Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs | |
AR055202A1 (es) | Derivados de imidazolcarboxamida como inhibidores de fructosa -1,6- biofosfatasa y composiciones farmaceuticas que los contienen | |
DE60142469D1 (de) | Imidinderivate als antineoplastika | |
AR032467A1 (es) | Derivados de piridina, procedimiento para prepararlos, el uso de dichos derivados para la preparacion de medicamentos y los medicamentos que contienen dichos derivados | |
BR0013792A (pt) | Derivados de amino-triazolopiridina | |
AR038762A1 (es) | Derivados de indolina, un proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion y el uso de dichos derivados para la fabricacion de un medicamento | |
RU94039542A (ru) | Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция | |
ES2158778B1 (es) | Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen. | |
AR048567A1 (es) | Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas. | |
PT887344E (pt) | Quinolinas e quinazolinas uteis em terapia | |
BR0213646A (pt) | Método, compostos e composição para controle de pragas invertebradas | |
BRPI0412502A (pt) | derivados de ariltiouréia substituìda úteis como inibidores de replicação viral | |
AR035945A1 (es) | Derivados de piperacina, su uso en la preparacion de medicamentos, procedimiento para la preparacion de dichos compuestos, composiciones farmaceuticas que comprenden dichos compuestos, y metodo para preparar dichas composiciones | |
PE20010299A1 (es) | DERIVADOS DE DECAHIDROISOQUINOLINA COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR iGLUR5 | |
AR059574A1 (es) | Formulaciones farmaceuticas acuosas de ligandos selectivos er-beta | |
ES2056146T3 (es) | Monopersulfatos de acidos amino-(poli)percarboxilicos. | |
PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
BR0213731A (pt) | Compostos de silìcio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |